Neudle.com: multiple sclerosis cost of

Differential
(Click to cross reference)

abdominal reflex, absent

acetylcholine receptor

acetylcholine receptor antibody

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

advances in neurology

adverse drug reaction

alemtuzumab

algorithm

amphiphysin antibodies

amyotrophic lateral sclerosis

ANA

angiotensin-converting enzyme

anti MAG antibodies

anti Ro antibody

area postrema

area postrema syndrome

basal ganglia, lesion of

CAT scan, emission, abnormal

CAT scan, indications for

central nervous system, infection of

cerebral edema, vasogenic

cerebral peduncle

cerebral vasculature

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, oligoclonal bands, absent

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, mimics

cervical spine manipulation

children

chiropractic manipulation

chorioretinitis

cladribine

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

controversies in neurology

conversion reaction

cop 1

corpus callosum

corpus callosum, lesion of

cytomegalovirus infection

demyelinating disease

dermatomyositis

diagnostic criteria

diencephalon

differential diagnosis

diplopia

disability, neurological

disease modifying agents

electroencephalogram, abnormalities of

embolism

embolism, cholesterol

employment

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

epidemiology of neurology

evidence-based research

fourth ventricle, floor

fumarate

gadolinium

gag reflex, depressed

gammaglobulin therapy, intravenous

gender

gray matter

Guillain Barre syndrome

heralding manifestation

herpes zoster

hiccoughs

hiccoughs, intractable

hyponatremia with cerebral disorders

hypothalamus

hypothalamus, damage to

hypothalamus, lesion of

hypothermia

iatrogenic neurologic disorders

idiopathic

immunohistochemistry

immunology and the nervous system

immunomodulation

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inclusion body myositis

inebilizumab

infection

infliximab

intellectual deterioration

intracerebral hemorrhage

lesions too numerous to count

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

level of consciousness, decreased

limbic encephalitis

linear lesion

lipoprotein receptor-related protein 4

lumbar spine manipulation

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

mammillary bodies

managed care

marihuana

McDonald criteria for MS

medical-legal aspects of neurology

medulla oblongata

medulla oblongata, lesion of

meningeal enhancement

mental status, abnormal

mesial temporal sclerosis

methotrexate

microangiopathy, spinal cord

microemboli

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebellar peduncle, lesion, bilateral

migraine

migraine, cost of

migraine, treatment of

mimics

misdiagnosis

mitoxantrone

monoclonal antibodies

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, field strength, high

MRI, spinal cord, increased intramedullary cord signal

MRI, spine

MRI, susceptibility weighted

MRI, target sign

MRS

multiple sclerosis

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, epidemiology of

multiple sclerosis, late-onset

multiple sclerosis, lesion location

multiple sclerosis, misdiagnosis

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, tumefactive

multiple sclerosis, without CSF bands

multiple sclerosis, work up for

multiple system atrophy

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myasthenic syndrome

myasthenic syndrome, treatment of

myelitis, longitudinal

myelitis, post infectious

myelitis, transverse

myelitis, transverse, idiopathic

myelitis, transverse, prognosis

myelitis, transverse, recurrent

myelopathy, necrotizing

myocarditis

myofascial pain syndrome

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic complications of, systemic cancer

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic disease, multiple

neurologic evaluation

neurologic symptoms, unexplained

neurology clinic

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica (Devic's disease), screening

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, peripheral, treatment

neuroradiology

NMDA antagonists

Oculinum

old age, neurology of

ophthalmoplegia

opportunistic infection

optic chiasm

optic chiasm, lesion of

optic nerve

optic nerve, enhancement

optic nerve, lesion of

optic neuritis

optic neuritis, alternating

optic neuritis, bilateral

optic neuritis, recurrent

optic neuropathy

optic neuropathy, ischemic

optical coherence tomography

outcome research

ovarian tumor

owl's eye sign of spinal cord

Parkinsonism syndrome

pathology

patient information and support

periaqueductal lesion

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

rehabilitation for neurologic disorders

remission

remote effect of cancer on the nervous system

respirator

respiratory failure

retinal lesion

reversible neurologic disorder

review article

risk factors

risk-benefit assessment

scleroderma, neurologic involvement with

screening

sedimentation rate, elevated

seizure

seizure, intractable

seizure, intractable, treatment of

seizure, surgical treatment of

seizure, treatment of

sensory level

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

seronegative

seropositive

shared decision making

single photon emission computed tomography

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

somnolence

spasticity

spasticity, treatment of

spinal cord

spinal cord, biopsy

spinal cord, compression of

spinal cord, dorsal subpial enhancement

spinal cord, enlargement

spinal cord, infarction of

spinal cord, lesion of

spinal cord, neoplasm

splenium of corpus callosum

sprain, cervical

sprain, cervical-treatment of

staphylococcal protein A column therapy

steroid

steroid therapy, CNS treatment and complications with

stiff man syndrome

strain, back

subarachnoid hemorrhage

sumatriptan

sweet taste

symmetric brain lesions

syringomyelia

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

tender points

teriflunomide

thalamus, lesion of

thalamus, lesion of-bilateral

third ventricle, wall

transient neurologic deficit

trauma

treatment of neurologic disorder

tuberculosis

tumefactive lesion

ultrasonography

ultrasonography, carotid artery

vision loss, sequential

vision, blurred

visual acuity

visual evoked response

visual loss

visual loss, progressive

visual loss, sudden

vomiting, intractable

Wallerian degeneration

water channel antibodies

weakness

weakness, acute

weakness, fatiguable

weakness, generalized

weakness, progressive

white matter disease

white matter disease, periventricular

whites

work loss

workers' compensation

workup

Showing articles 850 to 900 of 4442 << Previous Next >>

Relevance of Hypointense Lesions on Fast Fluid-Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple Sclerosis
AJNR 20:813-820, Rovaris,M.,et al, 1999

The Relationship of MS to Physical Trauma and Psychological Stress, Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 52:1737-1745, Goodin,D.S.,et al, 1999

Trigeminal Neuralgia Triggered by Auditory Stimuli in Multiple Sclerosis
Arch Neurol 56:731-733, Hartmann,M.,et al, 1999

Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999

General Neurologist and Subspecialist Care for Multiple Sclerosis, Patients' Perceptions
Neurol 53:1190-1197, Vickrey,B.G.,et al, 1999

Cavernous Haemangioma Mimicking Multiple Sclerosis
BMJ 318:1604-1605, Cader,M.Z.&Winer,J.B., 1999

Cerebrospinal Fluid Findings in CADASIL
Neurol 53:233, Dichgans,M.,et al, 1999

Lamotrigine Adjunctive Therapy in painful Phenomena in MS:Preliminary Observations
Neurol 53:433, Cianchetti,C.,et al, 1999

Encephalitis after Hepatitis B Vaccination, Recurrent Disseminated Encephalitis or MS?
Neurol 53:396-401, Tourbah,A.,et al, 1999

Chlamydia Pneumoniae Infection of the Central Nervous System in Multiple Sclerosis
Ann Neurol 46:6-14,4, Sriram,S.,et al, 1999

Benign Multiple Sclerosis? Clinical Course, Long Term Follow Up, and Assessment of Prognostic Factors
JNNP 67:148-152,138, Hawkins,S.A.&McDonnell,G.V., 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Chronic Thalamic Stimulation for the Tremor of Multiple Sclerosis
Neurol 53:625-628, Montgomery,E.B.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis
Neurol 53:139-148, Simon,J.H.,et al, 1999

Multiple Sclerosis in Children Under 6 Years of Age
Neurol 53:478-484, Ruggieri,M.,et al, 1999

The Contribution of Magnetic Resonance Imaging to the Diagnosis of Multiple Sclerosis
Neurol 53:448-456, Fazekas,F.,et al, 1999

Optic Neuritis as Onset Manifestations of Multiple Sclerosis
Neurol 53:473-478, Sorensen,T.L.,et al, 1999

Association of MS with Thyroid Disorders
Neurol 53:883-885, Karni,A.&Abramsky,O., 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Olfactory Dysfunction in Multiple Sclerosis:Relation to Longitudinal Changes in Plaque Numbers in Central Olfactory Structures
Neurol 53:880-882, Doty,R.L.,et al, 1999

Isolated Trochlear Nerve Palsy in Patients with Multiple Sclerosis
Neurol 53:877-879, Jacobson,D.M.,et al, 1999

Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999

The Phenotypic Spectrum of CADASIL:Clinical Findings in 102 Cases,
Ann Neurol 44:731-739,715, Dichgans,M.,et al, 1998

Surgical Treatment of Epilepsy in Tuberous Sclerosis,Strategies and Results in 18 Patients
Neurol 51:1263-1269, Guerreiro,M.M.,et al, 1998

A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998

Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998

Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998

Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Cerebellum in Attention-Deficit Hyperactivity Disorder
Neurol 50:1087-1093, Berquin,P.C.,et al, 1998

Clinicopath Conf
Demyelinating Process Consistent with Multiple Sclerosis, Case 26-1998, NEJM 339:542-549998., , 1998

A Comparison of Rectal Diazepam Gell and Placebo for Acute Repetitive Seizures
NEJM 338:1869-1875, 19161998., Dreifuss,F.E.,et al, 1998

The Predictive Value of CSF Ologoclonal Banding for MS 5 Years After Optic Neuritis
Neurol 51:885-887, Cole,S.R.,et al, 1998

Transverse Myelitis, Comparison with Spinal Cord Presentations of Multiple Sclerosis
Neurol 50:429-433, Scott,T.F.,et al, 1998

Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998

Assessment of Motor Function After Stereotactic Pallidotomy
Neurol 50:266-270, Ondo,W.G.,et al, 1998

Different Predictors of Neurolgoical Worsening in Different Causes of Stroke
Arch Neurol 55:481-486, Yamamoto,H.,et al, 1998

Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage
Stroke 29:798-804, Hopp,J.W.,et al, 1998

Showing articles 850 to 900 of 4442 << Previous Next >>